|
BIOLASE, INC.
Schedule II — Consolidated Valuation and Qualifying Accounts and Reserves
For the Years Ended December 31, 2021, 2020, and 2019
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
Charges |
|
|
|
|
|
|
|
|
|
Beginning |
|
|
(Reversals) to Cost |
|
|
|
|
|
Balance at |
|
|
|
of Year |
|
|
or Expenses |
|
|
Deductions |
|
|
End of Year |
|
Year Ended December 31, 2021: |
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for doubtful accounts |
|
$ |
4,017 |
|
|
$ |
(202 |
) |
|
$ |
(1,661 |
) |
|
$ |
2,154 |
|
Allowance for sales returns |
|
|
262 |
|
|
|
— |
|
|
|
— |
|
|
|
262 |
|
Allowance for tax valuation |
|
|
52,161 |
|
|
|
5,518 |
|
|
|
|
|
|
57,679 |
|
Year Ended December 31, 2020: |
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for doubtful accounts |
|
$ |
2,531 |
|
|
$ |
1,488 |
|
|
$ |
(2 |
) |
|
$ |
4,017 |
|
Allowance for sales returns |
|
|
210 |
|
|
|
87 |
|
|
|
(35 |
) |
|
|
262 |
|
Allowance for tax valuation |
|
|
53,222 |
|
|
|
(1,061 |
) |
|
|
— |
|
|
|
52,161 |
|
Year Ended December 31, 2019: |
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for doubtful accounts |
|
$ |
850 |
|
|
$ |
1,827 |
|
|
$ |
(146 |
) |
|
$ |
2,531 |
|
Allowance for sales returns |
|
|
210 |
|
|
|
— |
|
|
|
— |
|
|
|
210 |
|
Allowance for tax valuation |
|
|
46,967 |
|
|
|
6,366 |
|
|
|
(111 |
) |
|
|
53,222 |
|
|